Tirzepatide

STORAGE & HANDLING

Store lyophilized vials refrigerated; unopened powder may be frozen for long-term storage. Once reconstituted, keep at 2–8 °C, away from direct light.

PRODUCT INFORMATION

Dual-Pathway Metabolic Research | GIP + GLP-1 Receptor Agonist Tirzepatide is a synthetic peptide investigated for its effects on metabolic regulation, glucose control, appetite signalling and body weight. Unlike traditional GLP-1 receptor agonists, tirzepatide activates two incretin pathways — GIP and GLP-1 — which is what makes it particularly interesting in metabolic research.

AREAS OF RESEARCH INTEREST

• Dual Receptor Activity — Tirzepatide acts as an agonist at both GIP and GLP-1 receptors, two signalling systems involved in metabolism and glucose regulation.
• Metabolic Research — Clinical research has demonstrated substantial effects on blood-glucose regulation and metabolic markers in people with type 2 diabetes.
• Body-Weight Research — Large randomized clinical trials have found substantial average reductions in body weight during tirzepatide treatment, making weight management one of its most extensively studied applications.
• Appetite & Satiety — Its incretin-receptor activity influences pathways involved in appetite, satiety and energy intake.
• From Research to Medicine — Tirzepatide itself is no longer merely an experimental molecule: it is the active pharmaceutical ingredient in approved prescription medicines including Mounjaro and Zepbound. Those approvals apply to regulated pharmaceutical products — not independently manufactured research vials.